XYNOS KONSTANTINOS (Chief Medical Officer) sold 11.9% of their position (15.88K shares) of REPLIMUNE GROUP, INC. on the open market
Open‑market sale worth $119.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/10/2024ACC: 0001104659-24-070108
Officer· Chief Medical Officer
Since Dec 2022
-15.88K
Net shares
Net seller
$119.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
15.88K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−15.88K
Price / share
$7.50
Trade value
$119.11K
% of position
11.9%
6/7/2024
133.01K→117.13K
Total
Net shares
−15.88K
Net value
-$119.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/7/2024 | S · Sale | −15.88K | $7.50 | $119.11K | 11.9% | 133.01K | 117.13K |
| Total | −15.88K | -$119.11K | ||||||
Derivative Transactions0
No derivative transactions reported